Immunogenicity and Safety Study of Kinrix co-Administered With Varivax.

Trial Profile

Immunogenicity and Safety Study of Kinrix co-Administered With Varivax.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Nov 2016

At a glance

  • Drugs DTaP poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine; Varicella zoster virus vaccine live
  • Indications Chickenpox; Diphtheria; Measles; Mumps; Pertussis; Poliomyelitis; Rubella; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 02 Feb 2010 Actual patient number (478) added as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top